Literature DB >> 34916762

Reanalyzing the Mortality Analysis of COVID-19 Deaths in a Tertiary Care Center in India.

Abhijeet Anand1, Reecha Panghal2, Paridhi Kaler3, Saurabh Saigal1, Rajesh Panda1, Saiteja Kodamanchili1, Krishnkant Bhardwaj1, T B Gowthaman1.   

Abstract

How to cite this article: Anand A, Panghal R, Kaler P, Saigal S, Panda R, Kodamanchili S, et al. Reanalyzing the Mortality Analysis of COVID-19 Deaths in a Tertiary Care Center in India. Indian J Crit Care Med 2021; 25(10):1211.
Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.

Entities:  

Year:  2021        PMID: 34916762      PMCID: PMC8645815          DOI: 10.5005/jp-journals-10071-23982

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


Sir, Recently, one of the most awaited publications by the premier government medical institute of our country, titled “Clinicoepidemiological Features and Mortality Analysis of Deceased Patients with COVID-19 in a Tertiary Care Center”, was a very delightful read.[1] All the intensivists of India look up to this institute for regular guidelines of management of COVID-19. It is a very informative and learning piece analyzing mortality among the patients admitted to one of the (intensive care units) ICU of this center. When compared with other similar studies across the globe, this paper does not provide supplementary data that could have answered questions like how many of the admitted patients were intubated in total and what was the mortality rate among the subgroup who were intubated.[2,3] Rather a retrospective approach of data representation has been employed, which tells that among the total 247 deceased patients, 24.2% were intubated and 30.3% of total deceased were intubated within 24 hours. Even this representation does not throw light on how many patients of total 654 patients were intubated during their ICU stay. The policy guiding intubation of patients should also be specified as if it was decided by the intensivist on duty or by any fixed institutional criteria. The incidence of pulmonary embolism (PE) among the deceased in the original paper is 2.8%, which is quite less than reported by Mahmoud et al. in a meta-analysis who reported the overall PE rate in ICU to be 19%, and on autopsy, 22% of deceased patients were found to have PE in COVID-19.[4] The question that remains unanswered is how were those patients, who died in this published paper, diagnosed with PE. The diagnosis of PE was a clinical diagnosis or radiological diagnosis or by autopsy should have been specified. If the incidence of PE is so less than what was the antithrombotic practice of the institute as this piece of information can help to save many lives.

Orcid

Abhijeet Anand https://orcid.org/0000-0001-6498-5388 Reecha Panghal https://orcid.org/0000-0002-8695-5371 Paridhi Kaler https://orcid.org/0000-0002-3100-5133 Saurabh Saigal https://orcid.org/0000-0002-2364-2271 Rajesh Panda https://orcid.org/0000-0001-7123-876X Saiteja Kodamanchili https://orcid.org/0000-0003-1033-0321 Krishnkant Bhardwaj https://orcid.org/0000-0002-2207-0654 Gowthaman TB https://orcid.org/0000-0002-0301-3793
  4 in total

1.  Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.

Authors:  Giacomo Grasselli; Massimiliano Greco; Alberto Zanella; Giovanni Albano; Massimo Antonelli; Giacomo Bellani; Ezio Bonanomi; Luca Cabrini; Eleonora Carlesso; Gianpaolo Castelli; Sergio Cattaneo; Danilo Cereda; Sergio Colombo; Antonio Coluccello; Giuseppe Crescini; Andrea Forastieri Molinari; Giuseppe Foti; Roberto Fumagalli; Giorgio Antonio Iotti; Thomas Langer; Nicola Latronico; Ferdinando Luca Lorini; Francesco Mojoli; Giuseppe Natalini; Carla Maria Pessina; Vito Marco Ranieri; Roberto Rech; Luigia Scudeller; Antonio Rosano; Enrico Storti; B Taylor Thompson; Marcello Tirani; Pier Giorgio Villani; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

2.  Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis.

Authors:  Mahmoud B Malas; Isaac N Naazie; Nadin Elsayed; Asma Mathlouthi; Rebecca Marmor; Bryan Clary
Journal:  EClinicalMedicine       Date:  2020-11-20

3.  Clinicoepidemiological Features and Mortality Analysis of Deceased Patients with COVID-19 in a Tertiary Care Center.

Authors:  Richa Aggarwal; Ridhima Bhatia; Kshitija Kulshrestha; Kapil D Soni; Renjith Viswanath; Ashutosh K Singh; Karthik V Iyer; Puneet Khanna; Sulagna Bhattacharjee; Nishant Patel; Ajisha Aravindan; Anju Gupta; Yudhyavir Singh; Venkata Ganesh; Rakesh Kumar; Arshed Ayub; Shailender Kumar; Kellika Prakash; Vineeta Venkateswaran; Debesh Bhoi; Manish Soneja; Purva Mathur; Rajesh Malhotra; Naveet Wig; Randeep Guleria; Anjan Trikha
Journal:  Indian J Crit Care Med       Date:  2021-06

4.  Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19.

Authors:  Yang Wang; Xiaofan Lu; Yongsheng Li; Hui Chen; Taige Chen; Nan Su; Fang Huang; Jing Zhou; Bing Zhang; Fangrong Yan; Jun Wang
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.